Skip to main content

Implant

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
2100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Prevail Therapeutics
1 program
1
TeriparatidePhase 2Peptide1 trial
Active Trials
NCT01279187Terminated27Est. Nov 2015
Advanced Bionics
Advanced BionicsCA - Valencia
2 programs
ClearVoiceN/A1 trial
Sound Processing Strategy - ClearVoiceN/A
Active Trials
NCT01066780Completed48Est. Sep 2010
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
TeriparatidePHASE_2Peptide

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Prevail TherapeuticsTeriparatide
Advanced BionicsClearVoice

Clinical Trials (2)

Total enrollment: 75 patients across 2 trials

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

Start: Feb 2011Est. completion: Nov 201527 patients
Phase 2Terminated

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Start: Mar 2010Est. completion: Sep 201048 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.